1-12 of 12
Yi Zeng
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Superior Overall Survival with Blinatumomab Versus Chemotherapy As Pre-Transplant Consolidation Treatment in Children with High-Risk First-Relapse B-Cell Precursor Acute Lymphoblastic Leukemia (B-ALL): Longer Follow-up (FU) of a Phase 3 Randomized Controlled Trial (RCT)

Franco Locatelli, Gerhard Zugmaier, Carmelo Rizzari, Joan D Morris, Bernd Gruhn, Thomas Klingebiel, Rosanna Parasole, Christin Linderkamp, Christian Flotho, Arnaud Petit, Concetta Micalizzi, Yi Zeng, Deepali Dilip Pilankar, William N Kormany, Cornelia Eckert, Anja Moericke, Mary Sartor, Ondrej Hrusak, Christina Peters, Vaskar Saha, Luciana Vinti, Arend von Stackelberg
Journal: Blood
Blood (2021) 138 (Supplement 1): 1231.
https://doi.org/10.1182/blood-2021-145476
Published: 2021
Journal Articles

A Phase 1b Study of Blinatumomab Including Subcutaneous Administration in Relapsed / Refractory (R/R) Indolent Non Hodgkin's Lymphoma (NHL)

Giuseppe Rossi, Henry Miles Prince, Constantine S. Tam, Matthew Ku, Catherine Thieblemont, Leslie L. Popplewell, Martin Wermke, Corinne Haioun, Nicole Wong Doo, Andreas Viardot, Andrés J M Ferreri, Silvia Ferrari, Hansen L. Wong, Priti Kadu, Gerhard Zugmaier, Yi Zeng, Alessandro Rambaldi
Journal: Blood
Blood (2021) 138 (Supplement 1): 2436.
https://doi.org/10.1182/blood-2021-152822
Published: 2021
Journal Articles

Pak2 Regulates MDSC Development and Function

Yi Zeng, MD PhD, Seongmin Hahn, Jessica Stokes, Emely Hoffman, Jonathan Chernoff, MD PhD, Emmanuel Katsanis, MD
Journal: Blood
Blood (2016) 128 (22): 705.
https://doi.org/10.1182/blood.V128.22.705.705
Published: 2016
Journal Articles

Normal Hematopoiesis and Neurofibromin -Deficient Myeloproliferative Disease Require Erk

Karl Staser, PhD, Yi Zeng, MD, PhD, Su-jung Park, PhD, Steven D. Rhodes, Yongzheng He, M.D., Matthew A. Shew, Jeff Gehlhausen, Donna Cerabona, Shi Chen, Zejin Sun, MD, PhD, Grzegorz Nalepa, MD, PhD, Feng-chun Yang, M.D., Ph.D., D. Wade Clapp, MD
Journal: Blood
Blood (2012) 120 (21): 704.
https://doi.org/10.1182/blood.V120.21.704.704
Published: 2012
Journal Articles

Ezrin Regulates Hematopoietic Stem/Progenitor Cell Motility

Yi Zeng, MD, PhD, Karl Staser, PhD, Keshav Mohan Menon, Su-jung Park, PhD, Muithi Mwanthi, Li Jiang, D. Wade Clapp, MD
Journal: Blood
Blood (2011) 118 (21): 1282.
https://doi.org/10.1182/blood.V118.21.1282.1282
Published: 2011
Journal Articles

A Modified Foamy Viral Envelope Enhances Gene Transfer Efficiency and Reduces Toxicity of Lentiviral FANCA Vectors in Fanca-/- HSCs.

Zejin Sun, MD, PhD, Yan Li, MD, PhD, Jingling Li, MS, Shanbao Cai, MD, PhD, Yi Zeng, MD, PhD, Dirk Lindemann, PhD, Karen E Pollok, PhD, Helmut Hanenberg, MD, PhD, D. Wade Clapp, MD
Journal: Blood
Blood (2009) 114 (22): 696.
https://doi.org/10.1182/blood.V114.22.696.696
Published: 2009
Journal Articles

Induction of BCR-ABL–specific immunity following vaccination with chaperone-rich cell lysates derived from BCR-ABL + tumor cells

Yi Zeng, Michael W. Graner, Sylvia Thompson, Marilyn Marron, Emmanuel Katsanis
Journal: Blood
Blood (2005) 105 (5): 2016–2022.
https://doi.org/10.1182/blood-2004-05-1915
Published: 2005
Journal Articles

Tumor-Derived Chaperone-Rich Cell Lysate (CRCL) Can Be Effectively Combined with Syngeneic Bone Marrow Transplantation to Treat Bcr-abl + Leukemia in a Murine Model.

Xinchun Chen, MD, Yi Zeng, PhD, Gang Li, MD, Sylvia Thompson, Marjan Sepassi, M. Angela Romanoski, Michael W. Graner, PhD, Emmanuel Katsanis, MD
Journal: Blood
Blood (2004) 104 (11): 2971.
https://doi.org/10.1182/blood.V104.11.2971.2971
Published: 2004
Journal Articles

Tumor-derived, chaperone-rich cell lysate activates dendritic cells and elicits potent antitumor immunity

Yi Zeng, Hanping Feng, Michael W. Graner, Emmanuel Katsanis
Journal: Blood
Blood (2003) 101 (11): 4485–4491.
https://doi.org/10.1182/blood-2002-10-3108
Published: 2003
Journal Articles

Exogenous stress proteins enhance the immunogenicity of apoptotic tumor cells and stimulate antitumor immunity

Hanping Feng, Yi Zeng, Michael W. Graner, Anna Likhacheva, Emmanuel Katsanis
Journal: Blood
Blood (2003) 101 (1): 245–252.
https://doi.org/10.1182/blood-2002-05-1580
Published: 2003
Journal Articles

Stressed apoptotic tumor cells stimulate dendritic cells and induce specific cytotoxic T cells

Hanping Feng, Yi Zeng, Michael W. Graner, Emmanuel Katsanis
Journal: Blood
Blood (2002) 100 (12): 4108–4115.
https://doi.org/10.1182/blood-2002-05-1389
Published: 2002
Journal Articles

Stressed apoptotic tumor cells express heat shock proteins and elicit tumor-specific immunity

Hanping Feng, Yi Zeng, Luke Whitesell, Emmanuel Katsanis
Journal: Blood
Blood (2001) 97 (11): 3505–3512.
https://doi.org/10.1182/blood.V97.11.3505
Published: 2001